OncoTherapy Science, Inc. (TYO:4564)

Blueprint Medicines Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	833	527	1,117	1,836	2,899
Cash & Short-Term Investments	833	527	1,117	1,836	2,899
Cash Growth	58.06%	-52.82%	-39.16%	-36.67%	-38.49%
Accounts Receivable	98	35	123	399	152
Other Receivables	-	153	-	-	-
Receivables	98	188	123	399	152
Inventory	78	73	99	231	41
Other Current Assets	96	29	83	134	102
Total Current Assets	1,105	817	1,422	2,600	3,194
Property, Plant & Equipment	-	-	-	-	94
Long-Term Investments	49	49	89	84	74
Other Intangible Assets	-	-	-	-	4
Other Long-Term Assets	1	1	-	1	2
Total Assets	1,155	867	1,511	2,685	3,368
Current Income Taxes Payable	163	141	318	558	174
Other Current Liabilities	164	218	291	46	20
Total Current Liabilities	327	359	609	604	194
Long-Term Deferred Tax Liabilities	-	-	-	-	2
Other Long-Term Liabilities	100	155	48	102	97
Total Liabilities	427	514	657	706	293
Common Stock	50	50	789	789	50
Additional Paid-In Capital	27,516	26,322	24,793	24,793	24,054
Retained Earnings	-26,908	-26,092	-24,804	-23,686	-21,114
Comprehensive Income & Other	70	73	76	83	85
Total Common Equity	728	353	854	1,979	3,075
Shareholders' Equity	728	353	854	1,979	3,075
Total Liabilities & Equity	1,155	867	1,511	2,685	3,368
Net Cash (Debt)	833	527	1,117	1,836	2,899
Net Cash Growth	58.06%	-52.82%	-39.16%	-36.67%	-38.49%
Net Cash Per Share	3.19	2.48	5.80	9.79	16.44
Filing Date Shares Outstanding	271.64	239.34	206.64	192.64	176.33
Total Common Shares Outstanding	271.64	217.64	192.64	192.64	176.33
Working Capital	778	458	813	1,996	3,000
Book Value Per Share	2.68	1.62	4.43	10.27	17.44
Tangible Book Value	728	353	854	1,979	3,071
Tangible Book Value Per Share	2.68	1.62	4.43	10.27	17.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.